VIR

VIR

VIR

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2026 Q1 Apr 7, 2026 Jacob Fund - - CRCL, CRWD, HOOD, RDDT, VIR, WATT AI, Biotechnology, cybersecurity, Fintech, growth, innovation, small cap, technology VIR
WATT
HOOD
RDDT
CRCL

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Apr 9, 2026 Fund Letters Jacob Fund Vir Biotechnology Biotechnology Biotechnology Bull NASDAQ biotechnology, BiTEs, Immunotherapy, infectious diseases, Oncology, Phase 1 Data, Sanofi Partnership, T-Cell Engagers
Jan 8, 2026 Substack Everyone Hates Poetry Vir Biotechnology, Inc. Biotechnology Pharmaceuticals Bull NASDAQ Stock Market biotechnology, Cash Burn Rate, cash reserves, chronic hepatitis delta, drug development, enterprise value, financial influx, infectious diseases, License Agreement, milestone payments

BSD Shareholders of VIR

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
No investor data available.